Oxoisoaporphines and aporphines: Versatile molecules with anticancer Efects
Author
dc.contributor.author
Rodríguez Arce, Esteban
Author
dc.contributor.author
Cancino Rivera, Patricio
Author
dc.contributor.author
Arias Calderón, Manuel
Author
dc.contributor.author
Silva Matus, Paul
Author
dc.contributor.author
Saldías, Marianela
Admission date
dc.date.accessioned
2020-05-08T14:21:12Z
Available date
dc.date.available
2020-05-08T14:21:12Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
Molecules 2020, 25, 108
es_ES
Identifier
dc.identifier.other
10.3390/molecules25010108
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/174583
Abstract
dc.description.abstract
Cancer is a disease that involves impaired genome stability with a high mortality index globally. Since its discovery, many have searched for effective treatment, assessing different molecules for their anticancer activity. One of the most studied sources for anticancer therapy is natural compounds and their derivates, like alkaloids, which are organic molecules containing nitrogen atoms in their structure. Among them, oxoisoaporphine and sampangine compounds are receiving increased attention due to their potential anticancer effects. Boldine has also been tested as an anticancer molecule. Boldine is the primary alkaloid extract from boldo, an endemic tree in Chile. These compounds and their derivatives have unique structural properties that potentially have an anticancer mechanism. Different studies showed that this molecule can target cancer cells through several mechanisms, including reactive oxygen species generation, DNA binding, and telomerase enzyme inhibition. In this review, we summarize the state-of-art research related to oxoisoaporphine, sampangine, and boldine, with emphasis on their structural characteristics and the relationship between structure, activity, methods of extraction or synthesis, and anticancer mechanism. With an effective cancer therapy still lacking, these three compounds are good candidates for new anticancer research.
es_ES
Patrocinador
dc.description.sponsorship
CONICT+PAI/Convocatoria Nacional Subvención a la Instalación en la Academia (SIA), Convocatoria 2018 77180052